Table 1.
Author | Primary outcome | Competing risk | Binary time‐ | Continuous time‐ |
---|---|---|---|---|
varying covariate |
varying covariate |
|||
Han et al12 | Cervical cancer‐ | Death from other | Cumulative dose | |
specific mortality | causes | of metformin | ||
after cervical | ||||
cancer diagnosis | ||||
Ong et al13 | Death | Discharge from | The occurrence | |
the ICU | of a specific | |||
infection | ||||
Dautzenberg et al15 | ICU mortality | ICU discharge | Colonization by | |
a specific organism | ||||
Vajdic et al16 | Cause‐specific | Deaths from | Specific | Age, calendar |
mortality | other causes | infections and | year of follow‐ | |
undergoing | up, and number | |||
opioid | of episodes of | |||
substitution | opioid | |||
therapy | substitution | |||
therapy | ||||
Ong et al14 | Mortality | Liberation from | Viral reactivation | |
mechanical | status | |||
ventilator | ||||
support | ||||
Klein Hesselink et al17 | Atrial fibrillation | All‐cause | Use of neck | Cumulative |
mortality | radiotherapy | thyroid | ||
stimulating | ||||
hormone level | ||||
and radioiodine dose | ||||
Aksnessaether et al18 | Second cancer | Death | Treatment | |
Li et al19 | Acute coronary | Death | Antiviral | |
syndrome/end‐ | treatment | |||
stage renal | ||||
disease/ischaemic | ||||
stroke/retinopathy | ||||
Deka et al20 | Development of | Death | Androgen | |
depression | deprivation | |||
therapy | ||||
Mori et al21 | TCZ | TCZ | Clinical Disease | |
discontinuation | discontinuation | Activity Index | ||
due to secondary | due to remission | (as binary or | ||
loss of efficacy | or other reasons | categorical | ||
variable) | ||||
Yaffe et al22 | Dementia | Death | Number of | |
follow‐up visits | ||||
per year |